Terms: = Breast cancer AND ERCC3, RAD25, 2071, ENSG00000163161, GTF2H, TFIIH, BTF2, P19447, XPB AND Treatment
14 results:
1. Comparison of adverse events in partial- or whole breast radiotherapy: investigation of cosmesis, toxicities and quality of life in a meta-analysis of randomized trials.
Haussmann J; Budach W; Corradini S; Krug D; Jazmati D; Tamaskovics B; Bölke E; Pedotoa A; Kammers K; Matuschek C
Radiat Oncol; 2023 Nov; 18(1):181. PubMed ID: 37919752
[TBL] [Abstract] [Full Text] [Related]
2. Genetic variability of oxidative stress and DNA repair genes associated with pre-treatment cancer-related fatigue in women with breast cancer.
Davis T; Koleck T; Conway A; Bender C; Conley Y
Support Care Cancer; 2023 May; 31(6):345. PubMed ID: 37212918
[TBL] [Abstract] [Full Text] [Related]
3. Racial Disparities in Pathological Complete Response Among Patients Receiving Neoadjuvant Chemotherapy for Early-Stage breast cancer.
Zhao F; Miyashita M; Hattori M; Yoshimatsu T; Howard F; Kaneva K; Jones R; Bell JSK; Fleming GF; Jaskowiak N; Nanda R; Zheng Y; Huo D; Olopade OI
JAMA Netw Open; 2023 Mar; 6(3):e233329. PubMed ID: 36995716
[TBL] [Abstract] [Full Text] [Related]
4. Effect of breast Conservation Therapy vs Mastectomy on Overall Survival and breast cancer-Specific Survival Among Men With Stage I-II breast cancer: Analysis of SEER, 2000-2018.
He Y; Gao X; Wu J; Li X; Ma Z
Clin Breast Cancer; 2022 Jul; 22(5):410-417. PubMed ID: 35473920
[TBL] [Abstract] [Full Text] [Related]
5. Establishment and characterization of a new spontaneously immortalized ER
Nobili S; Mannini A; Parenti A; Raggi C; Lapucci A; Chiorino G; Paccosi S; Di Gennaro P; Vezzosi V; Romagnoli P; Susini T; Coronnello M
Sci Rep; 2021 Apr; 11(1):8340. PubMed ID: 33863935
[TBL] [Abstract] [Full Text] [Related]
6. Prevalence and reclassification of BRCA1 and BRCA2 variants in a large, unselected Chinese Han breast cancer cohort.
Liu Y; Wang H; Wang X; Liu J; Li J; Wang X; Zhang Y; Bai Z; Zhou Q; Wu Y; Shen Y; Weng X; Liu F; Guo J; Di L; Gires O; Zhang Z; Chen Y; Wang H
J Hematol Oncol; 2021 Jan; 14(1):18. PubMed ID: 33461583
[TBL] [Abstract] [Full Text] [Related]
7. Negative estrogen receptors and positive progesterone receptors breast cancers.
Delvallée J; Etienne C; Arbion F; Vildé A; Body G; Ouldamer L
J Gynecol Obstet Hum Reprod; 2021 Feb; 50(2):101928. PubMed ID: 33022450
[TBL] [Abstract] [Full Text] [Related]
8. Disruption of tfiih activities generates a stress gene expression response and reveals possible new targets against cancer.
Uriostegui-Arcos M; Aguayo-Ortiz R; Valencia-Morales MDP; Melchy-Pérez E; Rosenstein Y; Dominguez L; Zurita M
Open Biol; 2020 Jun; 10(6):200050. PubMed ID: 32543350
[TBL] [Abstract] [Full Text] [Related]
9. A Recurrent ercc3 Truncating Mutation Confers Moderate Risk for breast cancer.
Vijai J; Topka S; Villano D; Ravichandran V; Maxwell KN; Maria A; Thomas T; Gaddam P; Lincoln A; Kazzaz S; Wenz B; Carmi S; Schrader KA; Hart SN; Lipkin SM; Neuhausen SL; Walsh MF; Zhang L; Lejbkowicz F; Rennert H; Stadler ZK; Robson M; Weitzel JN; Domchek S; Daly MJ; Couch FJ; Nathanson KL; Norton L; Rennert G; Offit K
Cancer Discov; 2016 Nov; 6(11):1267-1275. PubMed ID: 27655433
[TBL] [Abstract] [Full Text] [Related]
10. cancer screening practices of cancer survivors: population-based, longitudinal study.
Grunfeld E; Moineddin R; Gunraj N; Del Giudice ME; Hodgson DC; Kwon JS; Elit L
Can Fam Physician; 2012 Sep; 58(9):980-6. PubMed ID: 22972732
[TBL] [Abstract] [Full Text] [Related]
11. A population-based study of follow-up care for Hodgkin lymphoma survivors: opportunities to improve surveillance for relapse and late effects.
Hodgson DC; Grunfeld E; Gunraj N; Del Giudice L
Cancer; 2010 Jul; 116(14):3417-25. PubMed ID: 20564062
[TBL] [Abstract] [Full Text] [Related]
12. Possible deleterious effect of tamoxifen in premenopausal women with locoregional recurrence of breast cancer.
Borner MM; Bacchi M; Castiglione M
Eur J Cancer; 1996 Nov; 32A(12):2173-6. PubMed ID: 9014762
[TBL] [Abstract] [Full Text] [Related]
13. [The dual function of the proliferating cell nuclear antigen (PCNA) in the response of human cells to UV damages].
Solov'eva LV; Svetlova MP; Hancock R; Whittle R; Lehmann AR; Bootsma D; Tomilin NV
Tsitologiia; 1996; 38(12):1294-302. PubMed ID: 9163104
[TBL] [Abstract] [Full Text] [Related]
14. Enhanced host cell reactivation capacity and expression of DNA repair genes in human breast cancer cells resistant to bi-functional alkylating agents.
Yen L; Woo A; Christopoulopoulos G; Batist G; Panasci L; Roy R; Mitra S; Alaoui-Jamali MA
Mutat Res; 1995 Nov; 337(3):179-89. PubMed ID: 7491121
[TBL] [Abstract] [Full Text] [Related]
